Author
Number of items: 54.
Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT 7 and κ‐opioid receptors' molecular interactions and isosteric replacement. (2025)
Giuseppe Floresta,
Alberto Granzotto,
Vincenzo Patamia,
Davide Arillotta,
Gabriele D. Papanti,
Amira Guirguis,
John M. Corkery,
Giovanni Martinotti,
Stefano L. Sensi
and
Fabrizio Schifano
Over-the-counter Psychosis : A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis. (2025)
Alessio Mosca,
Stefania Chiappini,
Gianluca Mancusi,
Andrea Miuli,
Carlotta Marrangone,
Rita Allegretti,
Serena Panichella,
Clara Cavallotto,
John Martin Corkery,
Mauro Pettorruso,
Giovanni Martinotti
and
Fabrizio Schifano
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders : A pharmacovigilance perspective. (2025)
S Chiappini,
A Guirguis,
N Schifano,
J Corkery,
F Semeraro,
A Mosca,
G D'Andrea,
G D Papanti,
D Arillotta,
G Floresta,
G Martinotti
and
F Schifano
Accelerating in translation: enhancing clinical and preclinical recovery from treatment-resistant depression with accelerated neuromodulation protocols. (2024)
M. Boffa,
G. d’Andrea,
L. De Risio,
S. Spalletti,
V. Zecca,
C. Cerri,
M. Bertone,
T. Singh,
G. Palombelli,
C. Cavallotto,
E. Výborová,
L.P. Padula,
I. Rosa,
R. Canese,
G. Di Lorenzo,
E. Pompili,
G. Nicolò,
S.L. Sensi,
G. Martinotti
and
F. Zoratto
Neuromodulation in a preclinical model of treatment-resistant depression: neurobehavioural effects of a standard protocol. (2024)
M. Boffa,
F. Martella,
S. Spalletti,
L. De Risio,
G. Di Lorenzo,
S.L. Sensi,
G. Martinotti,
C. D'Addario,
M. Pettorruso
and
F. Zoratto
Linking Striatal Dopaminergic Asymmetry with Personality Traits: Insights from Gambling Disorder. (2024)
Francesco Di Carlo,
Mauro Pettorruso,
Mario Santorelli,
Fabrizio Cocciolillo,
Giacomo d’Andrea,
Marco Di Nicola,
Stefano S. Sensi,
Giovanni Martinotti,
Jon E. Grant,
Giovanni Camardese
and
Daniela Di Giuda
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain. (2024)
Chiara Montemitro,
Alessio Mosca,
Stefania Chiappini,
Andrea Miuli,
Fabrizio Schifano,
Maria Josè Gordillo Montano,
Cristina Merino Del Villar,
Rita Allegretti,
Carlotta Marrangone,
Gilberto Di Petta,
Domenico De Berardis,
Mauro Pettorruso
and
Giovanni Martinotti
New trends of drug abuse in custodial settings: a systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. (2024)
Stefania Chiappini,
Giorgia Vaccaro,
Alessio Mosca,
Andrea Miuli,
Gianfranco Stigliano,
Giulia Stefanelli,
Giulia Giovannetti,
Rosalba Carullo,
Giacomo d'Andrea,
Francesco Di Carlo,
Clara Cavallotto,
Mauro Pettorruso,
Gilberto Di Petta,
John Martin Corkery,
Amira Guirguis,
Jacqueline L. Stair,
Giovanni Martinotti,
Seena Fazel
and
Fabrizio Schifano
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project). (2024)
Mauro Pettorruso,
Giorgio Di Lorenzo,
Beatrice Benatti,
Giacomo d’Andrea,
Clara Cavallotto,
Rosalba Carullo,
Gianluca Mancusi,
Ornella Di Marco,
Giovanna Mammarella,
Antonio D’Attilio,
Elisabetta Barlocci,
Ilenia Rosa,
Alessio Cocco,
Lorenzo Pio Padula,
Giovanna Bubbico,
Mauro Gianni Perrucci,
Roberto Guidotti,
Antea D’Andrea,
Laura Marzetti,
Francesca Zoratto,
Bernardo Maria Dell’Osso
and
Giovanni Martinotti
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown. (2024)
Ilaria De Luca,
Francesco Di Carlo,
Julius Burkauskas,
Artemisa R. Dores,
Irene P. Carvalho,
M. Ángeles Gómez-Martínez,
Attila Szabo,
Hironobu Fujiwara,
Cristina Monteiro Barbosa,
Marco Di Nicola,
Marianna Mazza,
Gabriele Sani,
Debora Luciani,
Mauro Pettorruso,
Massimo di Giannantonio,
Ilaria Cataldo,
Gianluca Esposito,
Giovanni Martinotti,
Thomas Zandonai,
Olivier Rabin
and
Ornella Corazza
Exploring the Association Between Suicidal Thoughts, Self-Injury, and GLP-1 Receptor Agonists in Weight Loss Treatments: Insights from Pharmacovigilance Measures and Unmasking Analysis. (2024)
Amira Guirguis,
Stephania Chiappini,
P G Duccio Papanti,
Rachel Vickers-Smith,
Daniel Harris,
John Corkery,
Davide Arillotta,
Giuseppe Floresta,
Giovanni Martinotti
and
Fabrizio Schifano
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18 F-FDG PET/CT Case Report. (2024)
Maria Pepe,
Marco Di Nicola,
Fabrizio Cocciolillo,
Stefania Chiappini,
Giovanni Martinotti,
Maria Lucia Calcagni
and
Gabriele Sani
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder. (2024)
Mauro Pettorruso,
Andrea Miuli,
Katia Clemente,
Gianluca Mancusi,
Giuseppe Migliara,
Francesco Di Carlo,
Giulia Pernaci,
Teresa Di Crosta,
Mario Santorelli,
Giacomo d’Andrea,
Luisa De Risio,
Mariaceleste Ciavarella,
Valentina Baccolini,
Ilenia Di Meo,
Ivana Cataldo,
Stefano L. Sensi
and
Giovanni Martinotti
Editorial: Comorbidity in bipolar disorder and schizophrenia, volume III. (2024)
Giovanni Martinotti,
Michele Fornaro
and
Domenico De Berardis
Aberrant salience in cannabis-induced psychosis: a comparative study. (2024)
Valerio Ricci,
Ilenia Di Muzio,
Franca Ceci,
Francesco Di Carlo,
Gianluca Mancusi,
Tommaso Piro,
Andrea Paggi,
Mauro Pettorruso,
Federica Vellante,
Domenico De Berardis,
Giovanni Martinotti
and
Giuseppe Maina
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. (2023)
Davide Arillotta,
Giuseppe Floresta,
Amira Guirguis,
John Martin Corkery,
Valeria Catalani,
Giovanni Martinotti,
Stefano L. Sensi
and
Fabrizio Schifano
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study. (2023)
Stefania Chiappini
and
Giovanni Martinotti
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. (2023)
Stefania Chiappini,
Rachel Vickers-Smith,
Daniel Harris,
G. Duccio Papanti Pelletier,
John Martin Corkery,
Amira Guirguis,
Giovanni Martinotti,
Stefano L. Sensi
and
Fabrizio Schifano
Investigating the effectiveness and tolerability of intranasal esketamine among older adults with treatment-resistant depression (TRD): a post-hoc analysis from the REAL-ESK study group. (2023)
Giacomo d’Andre,
Roger S. McIntyre,
Stefania Chiappini,
Giulia Stefanelli,
Rosalba Carullo,
Ileana Andriola,
Raffaella Zanardi,
Vassillis Martiadis,
Stefano L. Sensi,
Gabriele Sani,
Massimo Clerici,
Giorgio Di Lorenzo,
Antonio Vita,
Mauro Pettorruso
and
Giovanni Martinotti
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions. (2023)
Giacomo d’Andrea,
Gianluca Mancusi,
Maria Chiara Santovito,
Carlotta Marrangone,
Fabrizio Martino,
Mario Santorelli,
Andrea Miuli,
Francesco Di Carlo,
Maria Salvina Signorelli,
Massimo Clerici,
Mauro Pettorruso
and
Giovanni Martinotti
Functional Neurologic Disorders, disorders to be managed by neurologists, or are neurologists wandering in a dangerous field with inadequate resources? (2023)
Marco Onofrj,
Paola Ajdinaj,
Anna Digiovanni,
Naveed Malek,
Giovanni Martinotti,
Filippo Maria Ferro,
Mirella Russo,
Astrid Thomas
and
Stefano Luca Sensi
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression. (2023)
Giovanni Martinotti,
Bernardo Dell'Osso,
Giorgio Di Lorenzo,
Giuseppe Maina,
Alessandro Bertolino,
Massimo Clerici,
Stefano Barlati,
Gianluca Rosso,
Marco Di Nicola,
Matteo Marcatili,
Giacomo d'Andrea,
Clara Cavallotto,
Stefania Chiappini,
Sergio De Filippis,
Giuseppe Nicolò,
Pasquale De Fazio,
Ileana Andriola,
Raffaella Zanardi,
Domenica Nucifora,
Stefania Di Mauro,
Roberta Bassetti,
Mauro Pettorruso,
Roger S. McIntyre,
Stefano L. Sensi,
Massimo di Giannantonio,
Antonio Vita,
Giulia Baldacci,
Sandro Belletti,
Antonello Bellomo,
Beatrice Benatti,
Matteo Carminati,
Rosalba Carullo,
Domenico de Berardis,
Renato de Filippis,
Roberto Delle Chiaie,
Francesco di Carlo,
Gilberto Di Petta,
Alessandro Galluzzo,
Valentina Giorgelli,
Ginevra Lombardozzi,
Vassilis Martiadis,
Chiara Mattei,
Alessio Mosca,
Cinzia Niolu,
Miriam Olivola,
Mauro Percudani,
Maria Pepe,
Eros Rossi,
Maria Ilaria Scardigli
and
Filippo Tatì
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels’ Decline: A Narrative Review. (2022)
Nicolò Schifano,
Stefania Chiappini,
Alessio Mosca,
Andrea Miuli,
Maria Chiara Santovito,
Mauro Pettorruso,
Paolo Capogrosso,
Federico Dehò,
Giovanni Martinotti
and
Fabrizio Schifano
Knowledge and use of over-the-counter drugs in Italy: a survey-based study in the general population. (2022)
Stephania Chiappini,
Franca Ceci,
Alessio Mosca,
Francesco Di Carlo,
Julius Burkauskas,
Mauro Pettorruso,
Giovanni Martinotti,
Amira Guirguis,
John Martin Corkery,
Norbert Scherbaum,
Fabrizio Schifano
and
Massimo di Giannantonio
Alprazolam-related deaths in Scotland, 2004-2020. (2022)
John Martin Corkery,
Amira Guirguis,
Stefania Chiappini,
Giovanni Martinotti
and
Fabrizio Schifano
Contribution of drugs to drownings in Scotland, 1996-2020. (2022)
John Corkery,
Giovanni Martinotti
and
Fabrizio Schifano
Gender Differences in the Psychopathology of Obesity: How Relevant Is the Role of Binge Eating Behaviors? (2022)
Chiara Di Natale,
Lorenza Lucidi,
Chiara Montemitro,
Mauro Pettorruso,
Rebecca Collevecchio,
Lucia Di Caprio,
Luana Giampietro,
Liberato Aceto,
Giovanni Martinotti
and
Massimo di Giannantonio
Online Behaviours during the COVID-19 Pandemic and Their Associations with Psychological Factors: An International Exploratory Study. (2022)
Julius Burkauskas,
Naomi Fineberg,
Konstantinos Ioannidis,
Samuel Chamberlain,
Henrietta Bowden-Jones,
Inga Griskova-Bulanova,
Aiste Pranckeviciene,
Artemisa Dores,
Irene Carvalho,
Fernando Barbosa,
Pierluigi Simonato,
Ilaria De Luca,
Rosin Mooney,
Maria Gómez-Martínez,
Zsolt Demetrovics,
Krisztina Ábel,
Attila Szabo,
Hironobu Fujiwara,
Mami Shibata,
Alejandra Melero-Ventola,
Eva Arroyo-Anlló,
Ricardo Santos-Labrador,
Kei Kobayashi,
Francesco Di Carlo,
Cristina Monteiro,
Giovanni Martinotti
and
Ornella Corazza
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). (2022)
Stefania Chiappini,
Rachel Vickers-Smith,
Amira Guirguis,
John M. Corkery,
Giovanni Martinotti,
Daniel R. Harris
and
Fabrizio Schifano
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. (2022)
Stefania Chiappini,
Rachel Vickers-Smith,
Amira Guirguis,
John Martin Corkery,
Giovanni Martinotti
and
Fabrizio Schifano
Physical Activity and Exercise Addiction During the Covid-19 Pandemic in Italy. (2022)
Franca Ceci,
Francesco Di Carlo,
Julius Burkauskas,
Anatolia Salone,
Ilaria De Luca,
Dorotea Cicconcelli,
Valentina Giorgetti,
Irene La Fratta,
Antonino Todaro,
Pierluigi Simonato,
Giovanni Martinotti,
Massimo di Giannantonio
and
Ornella Corazza
An international cross-sectional investigation on social media, fitspiration content exposure, and related risks during the COVID-19 self-isolation period. (2022)
Ilaria Cataldo,
Julius Burkauskas,
Artemisa R. Dores,
Irene P. Carvalho,
Pierluigi Simonato,
Ilaria De Luca,
Maria Ángeles Gómez-Martínez,
Alejandra Rebeca Melero Ventola,
Zsolt Demetrovics,
Attila Szabo,
Krisztina Edina Ábel,
Mami Shibata,
Kei Kobayashi,
Hironobu Fujiwara,
Eva Maria Arroyo-Anlló,
Giovanni Martinotti,
Fernando Barbosa,
Inga Griskova-Bulanova,
Aiste Pranckeviciene,
Henrietta Bowden-Jones,
Gianluca Esposito
and
Ornella Corazza
Brexpiprazole as a new approach of treatment in somatization disorder. (2022)
Stefania Chiappini,
Alessio Mosca,
Giovanni Martinotti,
Francesco Di Carlo,
Andrea Miuli,
Luigi Dattoli,
Mauro Pettorruso
and
Massimo Di Giannantonio
Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. (2022)
Deborah Dal Farra,
Alice Valdesalici,
Giancarlo Zecchinato,
Alfio De Sandre,
Diego Saccon,
Pierluigi Simonato,
Ornella Corazza,
Giovanni Martinotti,
Andrew L. Smith
and
Marco Solmi
Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms. (2021)
Valerio Ricci,
Giovanni Martinotti,
Franca Ceci,
Stefania Chiappini,
Francesco Di Carlo,
Julius Burkauskas,
Ottavia Susini,
Debora Luciani,
Diego Quattrone,
Domenico De Berardis,
Mauro Pettorruso,
Giuseppe Maina
and
Massimo Di Giannantonio
An Italian survey of opioids misuse: Epidemiological and psychopathological aspects. (2021)
Gianfranco Stigliano,
Andrea Miuli,
Aliseo Lalli,
Maria Chiara Alessi,
Antonella Sociali,
Fabiana Esposito,
Laura D'Angelo,
Giacomo d'Andrea,
Alessio Mosca,
Maria Chiara Santovito,
Giovanni Martinotti
and
Massimo di Giannantonio
Knowledge and Use of Novel Psychoactive Substances in Italy: a Survey-Based Study in the General Population. (2021)
Caroline Zangani,
Edoardo Giuseppe Ostinelli,
Barbara Giordano,
Armando D’Agostino,
Giovanni Martinotti,
Massimo Clerici,
Orsola Gambini
and
Fabrizio Schifano
The factitious/malingering continuum and its burden on public health costs: a review and experience in an Italian neurology setting. (2021)
Marco Onofrj,
Anna Digiovanni,
Paola Ajdinaj,
Mirella Russo,
Claudia Carrarini,
Massimo Di Giannantonio,
Giovanni Martinotti
and
Stefano L. Sensi
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History. (2021)
Giovanni Martinotti,
Cristina Merino Del Villar,
Andrés Garcia Cordoba,
Lluís Andrés Tubau,
Ivan Castro Sánchez,
Francesco Di Carlo,
Stefania Chiappini,
Mauro Pettorruso,
Fabrizio Schifano
and
Massimo Di Giannantonio
Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. (2021)
Giovanni Martinotti,
Stefania Chiappini,
Mauro Pettorruso,
Alessio Mosca,
Andrea Miuli,
Francesco Di Carlo,
Giacomo D’Andrea,
Roberta Collevecchio,
Ilenia Di Muzio,
Stefano L. Sensi
and
Massimo Di Giannantonio
New Psychoactive Substances and suicidality: a systematic review of the current literature. (2021)
Stefania Chiappini,
Alessio Mosca,
A. Miuli,
Monica Chiara Santovito,
Laura Orsolini,
John Martin Corkery,
Amira Guirguis,
Mauro Pettorruso,
Giovanni Martinotti,
Massimo di Giannantonio
and
Fabrizio Schifano
New Psychoactive Substances (NPS) and Serotonin Syndrome onset: a Systematic Review. (2021)
Fabrizio Schifano,
Stephania Chiappini,
John Corkery,
Norbert Scherbaum,
Flavia Napoletano,
Davide Arillotta,
Valeria Catalani,
Alessandro Vento,
Mauro Pettorruso,
Giovanni Martinotti,
Massimo di Giannantonio
and
Amira Guirguis
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction. (2021)
Stefania Chiappini,
Fabrizio Schifano
and
Giovanni Martinotti
Learning to Deal with Problematic Usage of the Internet. (2020)
Naomi Fineberg,
Bernardo Dell'Osso,
Zsolt Demetrovics,
Samuel R. Chamberlain,
Ornella Corazza,
Joseph Zohar,
Marc Potenza,
Eric Hollander,
Michael Van Ameringen,
Célia M D Sales,
Julia Jones,
Natalie Hall,
Giovanni Martinotti,
Julius Burkauskas,
Josè M Menchon,
Edna Grünblatt
and
Orsolya Király
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients. (2020)
Giovanni Martinotti,
Raffaele Giorgetti,
Fabrizio Schifano
and
Massimo di Giannantonio
Substance Related Exogenous Psychosis: a post-modern syndrome. (2020)
Giovanni Martinotti,
Luisa De Risio,
Chiara Vannini,
Fabrizio Schifano,
Mauro Pettorruso
and
Massimo Di Giannantonio
Is Cyberchondria a New Transdiagnostic Digital Compulsive Syndrome? A Systematic Review of the Evidence. (2020)
Matteo Vismara,
Valentina Caricasole,
Vladan Starcevic,
Eduardo Cinosi,
Bernardo Dell'Osso,
Giovanni Martinotti
and
Naomi Fineberg
How deaths can help clinicians and policy-makers understand the risks of Novel Psychoactive Substances. (2020)
John Corkery,
Fabrizio Schifano
and
Giovanni Martinotti
The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings : A cross sectional study. (2019)
Ornella Corazza,
Pierluigi Simonato,
Zsolt Demetrovics,
Roisin Mooney,
Katinka van de Ven,
Andres Roman-Urrestarazu,
Lili Rácmolnár,
Ilaria De Luca,
Eduardo Cinosi,
Rita Santacroce,
Massimo Marini,
David Wellsted,
Keith Sullivan,
Giuseppe Bersani
and
Giovanni Martinotti
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon. (2019)
Ornella Corazza,
Robert Chilcott,
Giovanni Martinotti,
John Corkery,
Amira Guirguis,
Mire Zloh,
Shanna Marrinan
and
Valeria Catalani
Patterns of management of patients with dual disorder (psychosis) in Italy: a survey of psychiatrists and other physicians focusing on clinical practice. (2018)
Massimo Clerici,
Andrea De Bartolomeis,
Sergio De Filippis,
Giuseppe Ducci,
Icro maremmani,
Giovanni Martinotti
and
Fabrizio Schifano
Manifesto for a European research network into Problematic Usage of the Internet. (2018)
NA Fineberg,
Z Demetrovics,
Dan J. Stein,
K Ioannidis,
MN Potenza,
E Grünblatt,
M Brand,
J Billieux,
L Carmi,
DL King,
JE Grant,
M Yücel,
B Dell'Osso,
HJ Rumpf,
N Hall,
E Hollander,
A Goudriaan,
J Menchon,
J Zohar,
J Burkauskas,
G Martinotti,
M Van Ameringen,
O Corazza,
S Pallanti
and
SR Chamberlain
Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services. (2018)
Antonio Metastasio,
Attilio Negri,
Giovanni Martinotti
and
Ornella Corazza
Octodrine: New Questions and Challenges in Sport Supplements. (2018)
Valeria Catalani,
Mariya Prilutskaya,
Ahmed Al-Imam,
Shanna Marrinan,
Yasmine Elgharably,
Mire Zloh,
Giovanni Martinotti,
Robert Chilcott
and
Ornella Corazza